Full name: Laura Pina Vegas
Current country: France
Membership level: Associate
Type of membership: Member
Number of publications: 10
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop (2024)
https://pubmed.ncbi.nlm.nih.gov/38795763/
Comparison of biologics in psoriatic arthritis: an important clinical issue (2024)
https://pubmed.ncbi.nlm.nih.gov/37982745/
Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS) (2024)
https://pubmed.ncbi.nlm.nih.gov/38485454/
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS) (2023)
https://pubmed.ncbi.nlm.nih.gov/38114199/
Structural changes in the sacroiliac joint imaging in axial spondyloarthritis: from conventional radiography to magnetic resonance imaging? (2023)
https://pubmed.ncbi.nlm.nih.gov/36083026/
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study (2022)
https://pubmed.ncbi.nlm.nih.gov/34244706/
Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/34270707/
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database (2022)
https://pubmed.ncbi.nlm.nih.gov/35319735/
Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS) (2022)
https://pubmed.ncbi.nlm.nih.gov/36597983/
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database (2021)
https://pubmed.ncbi.nlm.nih.gov/32911531/